Inhibition of Na+, K+-ATPase activity in rat striatum by guanidinoacetate

International Journal of Developmental Neuroscience

Volumn 21, Issue 4, 2003, Pages 183-189

  Zugno, Alexandra I ^a   Stefanello, Francieli M ^a   Streck, Emilio L ^a   Calcagnotto, Thiago ^a   Wannmacher, Clóvis M D ^a   Wajner, Moacir ^a   Wyse, Angela T S ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Acetylcholinesterase; Guanidinoacetate; Kinetic studies; Na+, K+ ATPase; Rat; Striatum

Indexed keywords

ACETYLCHOLINESTERASE; ADENOSINE TRIPHOSPHATASE (MAGNESIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; ARGININE DERIVATIVE; ARGININIC ACID; ENZYME; GUANIDINOACETATE METHYLTRANSFERASE; GUANIDINOACETIC ACID; PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; ENZYME BINDING; ENZYME DEFICIENCY; ENZYME INHIBITION; ENZYME KINETICS; GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY; METABOLITE; MICHAELIS CONSTANT; NERVE CELL LESION; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN;

EID: 0038022922     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-5748(03)00038-8     Document Type: Article

References (55)

1. Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience. 14:1985;375-403.
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye-binding. Anal. Biochem. 72:1976;248-254.
3. 2+-stimulated ATPase activity. Anal. Biochem. 157:1986;375-380.
4. Chevillard C., Cárdenas M.L., Cornish-Bowden A. The competition plot: a simple test of whether two reactions occur at the same active site. Biochem. J. 289:1993;599-604.
5. Choi D.W., Rothman S.M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Ann. Rev. Neurosci. 13:1990;171-182.
6. Cousin M.A., Nicholls D.G., Pocock J.M. Modulation of ion gradients and glutamate release in cultured cerebellar granule cells by ouabain. J. Neurochem. 64:1995;2097-2104.
7. De Deyn P.P., Marescau B., Lornoy W., Becaus I., Lowenthal A. Guanidino compounds in uraemic dialysed patients. Clin. Chim. Acta. 157:1986;143-150.
8. Eggleton, P., Eggleton, G.P., 1927. The inorganic phosphate and a labile form of organic phosphate in the gastrocnemius of the frog. 21, 190-195.
9. Ellman G.L., Courtney K.D., Andres V., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:1961;21-29.
10. Erecinska M., Silver I.A. Ions and energy in mammalian brain. Prog. Neurobiol. 16:1994;37-71.
11. Everitt B.J., Robbins T.W. Central cholinergic systems and cognition. Ann. Rev. Psychol. 48:1997;649-684.
12. Hiramatsu, M., Ohba, S., Edamatsu, R., Kadowari, D., Mori, A., 1992. Effect of guanidino compounds on membrane fluidity of rat synaptosomes. In: De Deyn, P.P., Marescau, I.A., Quereshi, S.D., Mori, A. (Eds.), Guanidino Compounds in Biology and Medicine, vol. 1. John Libbey & Company Ltd., Guildford, UK, pp. 387-393.
13. Hyrayasu, Y., Morimoto, K., Otsuki, S., Mori, A., 1994. Increase of guanidinoacetic acid and methylguanidine in the brain following amygdala kindling in rats. In: De Deyn, P.P., Marescau, B., Stalon V., Qureshi, I.A. (Eds.), Guanidino Compounds in Biology and Medicine. John Libbey & Company, London, pp. 419-424.
14. Jones D.H., Matus A.I. Isolation of plasma synaptic membrane from brain by combination flotation-sedimentation density gradient centrifugation. Biochim. Biophys. Acta. 356:1974;276-287.
15. Kölker S., Okun J.G., Ahlemeyer B., Wyse A.T.S., Hölster F., Wajner M., Kohlmüller D., Mayatepek E., Krieglstein J., Hollffman G.F. Chronic treatment with glutaric acid induces partial tolerance to excitotoxicity in neuronal cultures from chick embryo telencephalons. J. Neurosci. Res. 68:2002;424-431.
16. Krebs H.A., Henseleit K. Untersuchungen über die Harnstroffbildung im Tierkörper. Hoppe-Seyler's. Z. Physiol. Chem. 210:1932;33-66.
17. Lees G.J. Contributory mechanisms in the causation of neurodegenerative disorders. Neuroscience. 54:1993;287-322.
18. Lees, G.J., Leong, W., 1995. Brain lesions induced by specific and non-specific inhibitors of sodium-potassium ATPase. 649, 225-233.
19. Lees G.J., Lehmann A., Sandberg M., Hamberger A. The neurotoxicity of ouabain, a sodium-potassium ATPase inhibitor, in rat hippocampus. Neurosci. Lett. 120:1990;159-162.
20. Leuzzi V., Bianchi M.C., Tosetti M., Carducci C., Cerquiglini C.A., Cioni G., Antonozzi I. Brain creatine depletion: guanidinoacetate methyltransferase deficiency (improving with creatine supplementation). Neurology. 14:2000;1407-1409.
21. Malcon C., Kaddurah-Daouk R., Beal M.F. Neuroprotective effects of creatine administration against NMDA and malonate toxicity. Brain Res. 860:2000;195-198.
22. Marescau B., Deshmukh D.R., Kockx M., Possemiers I., Qureshi I.A., Wiechert P., De Deyn P.P. Guanidino compounds in serum, urine, liver, kidney and brain of man and some urotelic animals. Metabolism. 41:1992;526-532.
23. +-ATPase activity. J. Neurochem. 27:1976;635-636.
24. Matsumoto M., Kobayashi K., Kishikawa H., Mori A. Convulsive activity of methylguanidine in cat and rabbits. IRCS Med. Sci. 4:1976;65.
25. Matsumoto M., Fujiwara M., Mori A., Robin Y. Effet des dérivés guanidiques sur la cholinestérase et sur l' acétylcholinestérase du cerveau de lapin. Comp. Rend. Soc. Biol. 171:1977;1226-1229.
26. Milatovic D., Dettbarn W.-D. Modification of acetylcholinesterase during adaptation to chronic, subacute paraoxon application in rat. Toxicol. Appl. Pharmacol. 136:1996;20-28.
27. Mori, A., 1996. Reactive oxygen species and mechanism of induction of seizure by guanidino compounds. In: Parker, L., Hiramatsu, M., Yoshikawa, T. (Eds.). Free Radicals in Brain Physiology and Disorders. Academic Press, New York, pp. 3-15.
28. Mori A., Kohno M., Masumizu T., Noda Y., Packer L. Guanidino compounds generate reactive oxygen species. Biochem. Mol. Biol. Int. 40:1996;135-143.
29. Moryama T., Nakahama H., Dukuhara Y., Horio M., Yanase M., Orita Y., Kamada T., Kanashoro M., Miyake Y. Decrease in the fluidity of brush-border membrane vesicles induced by gentamicin. A spin labeling study. Biochem. Pharmacol. 38:1989;1169-1174.
30. Neu A., Neuhoff H., Trube G., Fehr S., Ullrich K., Roeper J., Isbrandt D. Activation of GABA(A) receptors by guanidinoacetate: a novel pathophysiological mechanism. Neurobiol. Dis. 11:2002;298-307.
31. Olney J.W., Collins R.C., Sloviter R.S. Excitotoxic mechanisms of epileptic brain damage. Adv. Neurol. 44:1986;857-877.
32. +-ATPase activity in the synaptic plasma membrane from cerebral cortex of rats. Metab. Brain Dis. 26, 1321-1326.
33. +-ATPase from rat hippocampus by proline. Neurochem. Res. 26:2001;1321-1326.
34. Qureshi, I.A., Marescau, B., Lambert, M., Lemay, J.F., De Deyn, P.P., 1992. Guanidino compounds in HHH syndrome during sodium benzoate therapy. In: De Deyn, P.P., Marescau, B., Stalon, V., Qureshi, I.A. (Eds.), Guanidino Compounds in Biology and Medicine. Hartnolls, Cornwall, pp. 373-378.
35. +-ATPase in the brain. Epilepsy. 33:1992;58-64.
36. Satoh E., Nakasato Y. On the mechanism of ouabain-induced released of acetylcholine from synaptosomes. J. Neurochem. 58:1992;1038-1044.
37. Schetinger M.R.C., Porto N.M., Moretto M.B., Morsch V.M., Zanatta J.B.T.N. New benzodiazepines alter acetylcholinesterase and ATP-ase activities. Neurochem. Res. 25:2000;949-955.
38. Schreirer S., Polnazek C.F., Smith I.C.P. Spin labels in membrane: problem in practice. Biochim. Biophys. Acta. 553:1978;84-95.
39. Schulze A., Hess T., Wevers R., Mayatepek E., Bachert P., Marescau B., Knopp M.V., De Deyn P.P., Bremer H.J., Rating D. Creatine deficiency syndrome caused by guanidinoacetate methyltransferase deficiency: diagnostic tools for a new inborn error of metabolism. J. Pediatr. 131:1997;626-631.
40. Schulze A., Ebinger F., Rating D., Mayaetepek E. Improving treatment of guanidinoacetate methyltransferase deficiency: reduction of guanidinoacetic acid in body fluids by arginine restriction and ornithine supplementation. Mol. Genet. Metab. 74:2001;413-419.
41. Shiraga H., Hiramatsu M., Mori A. Convulsive activity of α-guanidino glutaric acid and the possible involvement of 5-hydroxytryptamine in the α-guanidino glutaric acid induced seizure mechanism. J. Neurochem. 47:1986;1832-1836.
42. +-ATPase activity from cerebral cortex by guanidino compounds accumulating in hyperargininemia. Brain Res. 838:1999;78-84.
43. Stöckler S., Holzbach U., Hanefeld F., Marquardt I., Helms G., Requart M., Hanicke W., Frahm J. Creatine deficiency in the brain: a new, treatable inborn error of metabolism. Pediatr. Res. 36:1994;409-413.
44. Stöckler S., Hanefeld F., Frahm J. Creatine replacement therapy in guanidinoacetate methyltransferase deficiency, a novel error of metabolism. Lancet. 348:1996;789-790.
45. +-ATPase activity by the metabolites accumulated in homocystinuria. Metab. Brain Dis. 17:2002;83-90.
46. +)-stimulated ATPase in brain. J. Biol. Chem. 254:1979;6060-6067.
47. +)-stimulated ATPase and acetylcholonesterase activities of dog brain synaptossomal plasma membranes. Biochem. J. 22:1984;301-307.
48. Verhelst J., Berwaerts J., Marescau B., Abs R., Neels H., Mahler C., De Deyn P.P. Serum creatine, creatinine, and other guanidino compounds in patients with thyroid dysfunction. Metabolism. 46:1997;1063-1067.
49. Villescas R., Ostwald R., Morimoto H., Bennett E.L. Effects of neonatal undernutrition and cold stress on behavior and biochemical brain parameters in rats. J. Nutr. 111:1981;1103-1110.
50. Von Figura, K., Hanefeld, F., Isbrandt, D., Stöckler-Ipsiroglu, S., 2001. Guanidinoacetate methyltransferase deficiency. In: Scriver, C.R., Beaudet, A.L., Sly, W.S., Valle, D. (Eds.), The Metabolic and Molecular Bases of Inherited Disease, eighth ed. McGraw-Hill, New York, pp. 1897-1908.
51. +-ATPase in synaptic plasma membranes from cerebral cortex of rats. Biochem. Soc. Trans. 23:1995;227S.
52. +-ATPase activity by phenylalanine and phenyllactate in the synaptic plasma membrane from the cerebral cortex of rats. Med. Sci. Res. 26:1998a;141-143.
53. +-ATPase activity from rat brain cortex by propionic acid. NeuroReport. 9:1998b;1719-1721.
54. +-ATPase activity in cerebral cortex of rats. NeuroReport. 11:2000;2311-2315.
55. Wyss M., Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol. Rev. 80:2000;1107-1213.